A nanocomposite hydrogel loaded with Ag nanoparticles reduced by aloe vera polysaccharides as an antimicrobial multifunctional sensor.

Developing high-performance hydrogels with anti-freeze, and antimicrobial properties is crucial for the practical application of flexible sensors. In this study, we prepared silver nanoparticles (AgNPs) with aloe polysaccharide (AP) as a reducing agent. Then, the AP/AgNPs were added to a system of polyvinyl alcohol and borax crosslinked in water/glycerol to obtain a multifunctional conductive hydrogel. The incorporated AgNPs improved the conductivity (0.39 S/m) and mechanical properties (elongation at break: 732.9 %, fracture strength: 1267.6 kPa) of the hydrogel. In addition, resultant hydrogel exhibited potential for sensing strain, temperature, and humidity. When used as a strain sensor, the hydrogel system exhibited low detection limit (0.1 %), and fast response (0.08 s). The resistance of the hydrogel decreased with an increase in the absorbed moisture content, enabling humidity detection (25-95 %) to monitor breathing status. As a temperature sensor, the hydrogel supported a wide detection range (-50 to +90 °C) and sensitivity (-30-0 °C, temperature coefficient of resistance (TCR) = -5.64 %/°C) to detect changes in the ambient temperature. This study proposes a simple method for manufacturing multifunctional hydrogel sensors, which broadens their application prospects in wearable sensing and electronic products.

A nanocellulose-based flexible multilayer sensor with high sensitivity to humidity and strain response for detecting human motion and respiration.

Biomass-based flexible sensors with excellent mechanical and sensing properties have attracted significant attention. In this study, based on the excellent dispersibility and degradability of nanocellulose crystals, we designed a polyvinyl alcohol/nanocellulose crystals/phytic acid (PCP) composite film with good flexibility and high sensitivity to humidity. A layer of multiwalled carbon nanotubes (MWCNT) and nanocellulose crystals (CNC) was further sandwiched between two PCP layers as a flexible multifunctional sensor (PCPW) to detect human movement and respiration. Phytic acid contains abundant phosphate groups that enhance proton conduction, allowing the PCPW composite film to change its electrical resistance in a sensitive and repeatable manner when the relative humidity was varied between 35 %-93 %. Meanwhile, CNC derived from sisal fibers enhanced the PCPW sensor's conductivity (3.3 S/m) and mechanical properties (elongation at break: 99 %) by improving the dispersion and connectivity of MWCNT. The PCPW sensor displayed a high sensitivity to strain (gauge factor: 49.5) and could monitor both facial expressions (smiling and winking) and the bending of joints. The sensor also generated stable electrical responses during breathing and blowing due to the change in humidity. Therefore, this biodegradable and multifunctional sensor has good application prospects.

In situ reduction of Ag nanoparticles using okra polysaccharides for the preparation of flexible multifunctional sensors.

This paper reports the fabrication of flexible films loaded with Ag nanoparticles (Ag NPs) and annotated as POPA films from polyvinyl alcohol, okra polysaccharides, phytic acid, and AgNO3 via an in situ reduction and solution-casting method. The prepared films exhibit strain, temperature, and humidity sensing. As a flexible strain sensor, the POPA sensor has a wide strain sensing range (1-250 %), and fast response/recovery (0.22/0.28 s), while as a temperature sensor, it senses the human body temperature and exhibits excellent temperature sensitivity (TCR = -1.401 % °C-1) and good linearity (R2 = 0.994) in the temperature range of 30-55 °C. Additionally, in the relative humidity (RH) of range 35-95 %, the POPA humidity sensor outputs stable electrical signals during adsorption and desorption. Moreover, it exhibits low hysteresis values (3.19 % RH) and good linearity (R2 = 0.989) for the detection of breathing rates during different human body states. Consequently, the POPA sensor exhibits good stability, repeatability, and reversibility for strain, temperature, and humidity sensing. The designed multifunctional POPA sensor thus holds great potential for its application in flexible wearable devices and electronics.

Highly stretchable anti-freeze hydrogel based on aloe polysaccharides with high ionic conductivity for multifunctional wearable sensors.

Conductive hydrogels have limitations such as non-degradability, loss of electrical conductivity at sub-zero temperatures, and single functionality, which limit their applicability as materials for wearable sensors. To overcome these limitations, this study proposes a bio-based hydrogel using aloe polysaccharides as the matrix and degradable polyvinyl alcohol as a reinforcing material. The hydrogel was crosslinked with borax in a glycerol-water binary solvent system, producing good toughness and compressive strength. Furthermore, the hydrogel was developed as a sensor that could detect both small and large deformations with a low detection limit of 1 % and high stretchability of up to 300 %. Moreover, the sensor exhibited excellent frost resistance at temperatures above -50 °C, and the gauge factor of the hydrogel was 2.86 at 20 °C and 2.12 at -20 °C. The Aloe-polysaccharide-based conductive hydrogels also functioned effectively as a wearable sensor; it detected a wide range of humidities (0-98 % relative humidity) and exhibited fast response and recovery times (1.1 and 0.9 s) while detecting normal human breathing. The polysaccharide hydrogel was also temperature sensitive (1.737 % °C-1) and allowed for information sensing during handwriting.

Biodegradable ion-conductive polyvinyl alcohol/okra polysaccharide composite films for fast-response respiratory monitoring sensors.

Polyvinyl alcohol (PVA) and okra polysaccharide (OP) are biodegradable polymers with high hydrophilicity and good biocompatibility with potential for use as flexible humidity-sensitive materials. Herein, biodegradable flexible composite films (named POP films) were prepared from PVA, OP, and phytic acid using a solution-casting method based on. POP films exhibited excellent mechanical strength, flexibility, flame retardancy, water resistance, humidity response, and humidity-sensing characteristics. Notably, the POP humidity sensors exhibited a hysteresis value of 1.88 % relative humidity for the adsorption and desorption processes and good sensitivity over a wide humidity range of 35-95 %. In addition, the humidity sensor distinguished the frequency of nose breathing, and its response and recovery times were 0.9 and 1.98 s, respectively. The excellent performance of POP sensors in monitoring humidity and human respiratory rates demonstrates the sensor's potential for wearable smart devices.

Pembrolizumab plus chemotherapy for advanced non-small-cell lung cancer without tumor PD-L1 expression in Asia.

Aim: We pooled patient-level data from three randomized controlled studies to evaluate the combination of pembrolizumab plus chemotherapy in patients with untreated advanced/metastatic non-small-cell lung cancer (NSCLC) and programmed cell death ligand 1 (PD-L1) tumor proportion score <1% in East Asia. Methods: The analysis included 107 patients from China, Japan, Korea, Thailand and Taiwan (pembrolizumab plus chemotherapy, n = 56; chemotherapy alone, n = 51). Results: For pembrolizumab plus chemotherapy versus chemotherapy alone, median overall survival was 21.3 versus 12.6 months (HR, 0.55 [95% CI: 0.35-0.87]) and median progression-free survival was 8.4 versus 6.0 months (HR, 0.64 [95% CI: 0.43-0.96]). Conclusion: The analysis supports the use of pembrolizumab in combination with platinum-based chemotherapy for East Asian patients with PD-L1-negative, advanced NSCLC.

This analysis evaluated outcomes for East Asian patients with a type of advanced lung cancer which does not express a protein called programmed cell death ligand 1 (PD-L1). The patients received either an immunotherapy, called pembrolizumab, in combination with chemotherapy or chemotherapy alone. Overall survival (how long people live) and progression-free survival (how long people live without their disease getting worse) were longer for patients who received treatment with pembrolizumab plus chemotherapy versus those who received chemotherapy alone. Side effects among East Asian patients were similar to those previously described for a global patient population. These results support the use of pembrolizumab in combination with chemotherapy for East Asian patients with lung cancer that does not express PD-L1. Clinical Trial Registration: NCT02039674; NCT02578680; NCT03950674; NCT02775435; NCT03875092 (ClinicalTrials.gov).

PD-L1 Expression in Chinese Patients with Advanced Non-Small Cell Lung Cancer (NSCLC): A Multi-Center Retrospective Observational Study.

Objective: This study aimed to investigate the prevalence of tumor programmed death-ligand 1 (PD-L1) expression in Chinese patients with advanced Non-Small Cell Lung Cancer (NSCLC). Methods: Tumor tissues with histologically confirmed stage IIIB/IV NSCLC were retrospectively obtained from 10 centers in China. PD-L1 expression was determined using the PD-L1 IHC 22C3 pharmDx kit (Agilent, Santa Clara, CA, USA) and the samples were repetitively assayed with the PD-L1 IHC 22C3 Ab concentrate (Agilent, Santa Clara, CA, USA). Results: Out of 901 patients who met the inclusion criteria, 879 (97.6%) had evaluable PD-L1 data. The number of patients with a PD-L1 tumor proportion score (TPS) < 1%, 1-49%, and ≥ 50% (corresponding to PD-L1 non-expression, low expression, and high expression) was 424 (48.2%), 266 (30.3%), and 189 (21.5%), respectively. PD-L1 expression was more likely to be found in patients younger than 75 years, men, current or former smokers, those with good performance status (PS) scores, and those with a wild-type epidermal growth factor receptor (EGFR). PD-L1 TPS ≥ 50% and ≥ 1% were respectively 28.0% and 50.2% among patients negative for both EGFR mutation and anaplastic lymphoma kinase (ALK) rearrangement. PD-L1 expression determined using the 22C3 antibody concentrate and pharmDx kit had comparable results. Conclusions: The prevalence of PD­L1 expression in advanced NSCLC was consistent with that reported in the global EXPRESS study. Age, gender, smoking history, PS scores, and EGFR/ALK mutation status affected PD-L1 expression. The 22C3 antibody concentrate appears to be an alternative reagent for the PD-L1 assay.